A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease

[1]  A. Griffiths,et al.  A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease , 2023, Journal of the Canadian Association of Gastroenterology.

[2]  N. Roberts,et al.  Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures , 2022, PharmacoEconomics.

[3]  Alan Lamb,et al.  The Challenges of Measuring and Valuing Quality of Life in Preschool Children: A Retrospective Review of NICE Appraisals , 2021, Children.

[4]  A. Griffiths,et al.  An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease , 2021, Children.

[5]  A. Griffiths,et al.  The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. , 2020, Journal of Crohn's & colitis.

[6]  A. Griffiths,et al.  Phenotypic variation in paediatric IBD by age: a multi-centre prospective inception cohort study of the Canadian Children IBD Network. , 2019, Journal of Crohn's & colitis.

[7]  J. Marshall,et al.  A Cost-Utility Analysis of Switching from Reference to Biosimilar Infliximab Compared to Maintaining Reference Infliximab in Adult Patients with Crohn’s Disease , 2020, Journal of the Canadian Association of Gastroenterology.

[8]  J. Hoch,et al.  Health-related quality of life in neonates and infants: a conceptual framework , 2020, Quality of Life Research.

[9]  Donna Rowen,et al.  Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? , 2020, PharmacoEconomics.

[10]  J. Madan,et al.  Patterns, trends and methodological associations in the measurement and valuation of childhood health utilities , 2019, Quality of Life Research.

[11]  A. Griffiths,et al.  Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's disease. , 2019, Gastrointestinal endoscopy.

[12]  G. Kaplan,et al.  The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD , 2018, Journal of the Canadian Association of Gastroenterology.

[13]  P. Moayyedi,et al.  Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease , 2018, Journal of the Canadian Association of Gastroenterology.

[14]  C. Hewitt,et al.  Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. , 2018, Inflammatory bowel diseases.

[15]  G. Savoye,et al.  Dramatic Increase in Incidence of Ulcerative Colitis and Crohn’s Disease (1988–2011): A Population-Based Study of French Adolescents , 2018, The American Journal of Gastroenterology.

[16]  Jason Madan,et al.  A Systematic Review and Meta-analysis of Childhood Health Utilities , 2017, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  D. Tanyingoh,et al.  Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases , 2017, The American Journal of Gastroenterology.

[18]  Krzysztof Piotr Malinowski,et al.  Health utility of patients with Crohn’s disease and ulcerative colitis: a systematic review and meta-analysis , 2016, Expert review of pharmacoeconomics & outcomes research.

[19]  Joffre Swait,et al.  Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. , 2016, Social science & medicine.

[20]  John Brazier,et al.  Nothing About Us Without Us? A Comparison of Adolescent and Adult Health-State Values for the Child Health Utility-9D Using Profile Case Best-Worst Scaling. , 2016, Health economics.

[21]  M. Friger,et al.  Health-Related Utility Weights in a Cohort of Real-World Crohn's Disease Patients. , 2015, Journal of Crohn's & colitis.

[22]  Mehdi Najafzadeh,et al.  Parents and adolescents preferences for asthma control: a best-worst scaling choice experiment using an orthogonal main effects design , 2015, BMC Pulmonary Medicine.

[23]  Julie Ratcliffe,et al.  A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations , 2015, PharmacoEconomics.

[24]  G. Guariso,et al.  Crohn's disease and growth deficiency in children and adolescents. , 2014, World journal of gastroenterology.

[25]  M. Zilbauer,et al.  Outcome measures in paediatric IBD: Data from a tertiary level center in UK , 2013 .

[26]  Katherine Stevens,et al.  Valuation of the Child Health Utility 9D Index , 2012, PharmacoEconomics.

[27]  David C. Wilson,et al.  Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines , 2012, Journal of pediatric gastroenterology and nutrition.

[28]  T. Nick,et al.  Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders , 2012, PharmacoEconomics.

[29]  J. Brazier,et al.  Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[30]  A. Griffiths,et al.  Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions , 2012, Inflammatory bowel diseases.

[31]  Wendy J. Ungar,et al.  Challenges in Health State Valuation in Paediatric Economic Evaluation , 2011, PharmacoEconomics.

[32]  Katherine Stevens,et al.  Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation , 2011, Applied health economics and health policy.

[33]  G. Guyatt,et al.  Assessing disease activity in ulcerative colitis: Patients or their physicians? , 2010, Inflammatory bowel diseases.

[34]  K. Stevens,et al.  Working With Children to Develop Dimensions for a Preference-Based, Generic, Pediatric, Health-Related Quality-of-Life Measure , 2010, Qualitative health research.

[35]  Katherine Stevens,et al.  Developing a descriptive system for a new preference-based measure of health-related quality of life for children , 2009, Quality of Life Research.

[36]  T. To,et al.  Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data , 2009, Gut.

[37]  A. Griffiths,et al.  Appraisal of the pediatric ulcerative colitis activity index (PUCAI) , 2009, Inflammatory bowel diseases.

[38]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[39]  M. Aalabaf-Sabaghi.  Decision modelling for health economic evaluation , 2007, Journal of Epidemiology and Community Health.

[40]  A. Griffiths,et al.  Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. , 2007, Gastroenterology.

[41]  Julie Ratcliffe,et al.  Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[42]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[43]  A. Griffiths,et al.  Health‐related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[44]  D. Feeny,et al.  The Health Utilities Index (HUI®): concepts, measurement properties and applications , 2003, Health and quality of life outcomes.

[45]  D. Feeny,et al.  Health utility estimation , 2002, Expert review of pharmacoeconomics & outcomes research.

[46]  C. Eiser,et al.  The measurement of quality of life in children: past and future perspectives. , 2001, Journal of developmental and behavioral pediatrics : JDBP.

[47]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[48]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.

[49]  M. Muise,et al.  Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network , 2020 .

[50]  C. Hewitt,et al.  Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. , 2018, Inflammatory bowel diseases.

[51]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[52]  Dean A. Regier,et al.  Evaluating health-related quality-of-life studies in paediatric populations , 2012, PharmacoEconomics.

[53]  L. Cipriano,et al.  Guidelines for the Economic Evaluation of Health Technologies: Canada , 2012 .

[54]  K. Stevens.  Valuation of the Child Health Utility Index 9D (CHU9D) , 2010 .

[55]  L. Matza,et al.  Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[56]  Ian McDowell,et al.  The Theoretical and Technical Foundations of Health Measurement , 1996 .